Mellon was invited to present its innovative Switch® suturing technology at the Dutch Vascular Course in Copenhagen, Denmark. The course took place 24-27 September 2016, just ahead of the Annual Meeting of the European Society for Vascular Surgery.
Dr. Mark Vrancken Peeters, CMO of Mellon, demonstrated the suturing device to 60 of his former colleagues. The technology was well received by the attendees. The Switch® is perceived as a promising innovation, that is expected to decrease complications in vascular surgery, therewith increasing the probability of a better patient outcome and reducing healthcare cost. The attending surgeons are looking forward to market introduction of the Switch®, so they can start using the device in humans.